Associations Between Cognitive Impairment and Neuroimaging in Patients with Multiple Sclerosis

Arch Clin Neuropsychol. 2024 Feb 19;39(2):196-203. doi: 10.1093/arclin/acad070.

Abstract

Objective: Multiple sclerosis (MS) is a debilitating inflammatory and neurodegenerative disease which commonly involves cognitive dysfunction. Magnetic resonance imaging (MRI) studies have shown that patients with MS (pwMS) have diffuse patterns of brain atrophy, however, the relationship between the presentation of cognitive dysfunction and brain tissue loss remains understudied. Given the integral function of thalamus as a central nervous system relay center and its involvement in various brain circuits, thalamic atrophy may play a key role in the development and progression of cognitive dysfunction. The purpose of this study is to examine the relationship between cognitive impairment in pwMS and thalamic atrophy.

Methods: A total of 121 pwMS who had neuropsychological testing and quantitative MRI within 1 year of each were retrospectively identified. Grouped LASSO linear regression with 10-fold cross validation was used to estimate each neuropsychological test score with thalamic volume as the focal predictor and all other demographic and MRI metrics as covariates.

Results: Rates of impairment ranged from 19% to 44%. Results showed notable associations between thalamic volume and Symbol Digit Modalities Test (β = 0.11), Brief Visuospatial Memory Test, delayed (β = 0.12), California Verbal Learning Test, delayed and total (β = 0.24 and β = 0.15 respectively), and Trail Making Test Part A (β = -0.01), after adjusting for covariates.

Conclusions: These findings demonstrate an independent association between thalamic volumes and processing speed and memory performance, after accounting for demographic, clinical, and other MRI variables, among pwMS.

Keywords: Executive functions; Learning and memory; Multiple sclerosis; Neuroimaging (structural).

MeSH terms

  • Atrophy / complications
  • Cognitive Dysfunction* / complications
  • Cognitive Dysfunction* / etiology
  • Humans
  • Magnetic Resonance Imaging
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / diagnostic imaging
  • Neurodegenerative Diseases* / complications
  • Neuroimaging
  • Neuropsychological Tests
  • Retrospective Studies